AMGEN INC
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (805)447-1000
EIN: 953540776
State Location: CA
State of Inc.: DE
- Nasdaq:AMGN
Form: 10-Q
Filing Date: 01 May 2026Report Date: 31 Mar 2026
Accepted: 30 Apr 2026 05:04 p.m.
Accession Number: 0000318154-26-000057
File Number: 001-37702
Film Number: 26928154
Documents
Primary Document: 10-Q
Accepted: 30 Apr 2026 05:04 p.m.
0000318154-26-000057-index-headers.html
Last Modified: 30 Apr 2026 05:04 p.m.
0000318154-26-000057-index.html
Last Modified: 30 Apr 2026 05:04 p.m.
0000318154-26-000057.txt
Last Modified: 30 Apr 2026 05:04 p.m.
0000318154-26-000057-xbrl.zip
Last Modified: 30 Apr 2026 05:04 p.m.
amgn-20260331.xsd
Last Modified: 30 Apr 2026 05:04 p.m.
amgn-20260331_cal.xml
Last Modified: 30 Apr 2026 05:04 p.m.
amgn-20260331_def.xml
Last Modified: 30 Apr 2026 05:04 p.m.
amgn-20260331_htm.xml
Last Modified: 30 Apr 2026 05:04 p.m.
amgn-20260331_lab.xml
Last Modified: 30 Apr 2026 05:04 p.m.
amgn-20260331_pre.xml
Last Modified: 30 Apr 2026 05:04 p.m.
amgn-ex31_20260331x10xq.htm
Last Modified: 30 Apr 2026 05:04 p.m.
amgn-ex32_20260331x10xq.htm
Last Modified: 30 Apr 2026 05:04 p.m.
FilingSummary.xml
Last Modified: 30 Apr 2026 05:04 p.m.
MetaLinks.json
Last Modified: 30 Apr 2026 05:04 p.m.
R1.htm
Last Modified: 30 Apr 2026 05:04 p.m.
R10.htm
Last Modified: 30 Apr 2026 05:04 p.m.
R11.htm
Last Modified: 30 Apr 2026 05:04 p.m.
R12.htm
Last Modified: 30 Apr 2026 05:04 p.m.
R13.htm
Last Modified: 30 Apr 2026 05:04 p.m.
R14.htm
Last Modified: 30 Apr 2026 05:04 p.m.
R15.htm
Last Modified: 30 Apr 2026 05:04 p.m.
R16.htm
Last Modified: 30 Apr 2026 05:04 p.m.
R17.htm
Last Modified: 30 Apr 2026 05:04 p.m.
R18.htm
Last Modified: 30 Apr 2026 05:04 p.m.